STOCK TITAN

GeoVax Labs New (GOVX) Stock News, Oct-Nov 2023

GOVX NASDAQ

GeoVax Labs, Inc. reports developments from a clinical-stage biotechnology business focused on vaccines and immunotherapies for infectious diseases and cancer. Recurring updates cover its MVA-based vaccine platform, the GEO-MVA candidate for mpox, smallpox and other poxviruses, GEO-CM04S1 as a multi-antigen COVID-19 vaccine, and Gedeptin as an oncolytic gene-directed therapy for solid tumors.

Company news also includes clinical-trial data reviews, government-supported program updates, patent activity tied to MVA-VLP technology and MUC1 tumor-associated antigen immunotherapy, financial results, and corporate presentations at healthcare and growth-company conferences.

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.38%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.87%
Tags
conferences
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.73%
Tags
clinical trial covid-19
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.78%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.65%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.43%
Tags
conferences earnings
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.42%
Tags
clinical trial covid-19
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.21%
Tags
conferences
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.11%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.23%
Tags
none

FAQ

What is the current stock price of GeoVax Labs New (GOVX)?

GeoVax Labs New (GOVX) last closed at $1.81.

What is the market cap of GeoVax Labs New (GOVX)?

The market cap of GeoVax Labs New (GOVX) is approximately $985.5K.